Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|March 1, 1995
(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infectionT W Vahlenkamp, A De Ronde, J Balzarini, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidinesErik De Clercq, G Andrei, J Balzarini, et al.
FEBS Letters|June 30, 1997
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virusJ Balzarini, J Kruining, O Wedgwood, et al.
International Journal of Pharmaceutics|February 13, 2002
Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781S Deferme, J Van Gelder, F Ingels, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 24, 1998
Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virusK Hartmann, M Kuffer, J Balzarini, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agentsE De Clercq, G Andrei, R Snoeck, et al.
International Journal of Pharmaceutics|September 16, 1999
Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPAJ Van Gelder, M Witvrouw, C Pannecouque, et al.
Pharmaceutical Research|April 2, 1998
Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayersP Annaert, G Gosselin, A Pompon, et al.
Microbiology Spectrum|June 15, 2026
New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutationsS Rimaux, M F Oliva, C Mestdagh, et al.
Nature Communications|November 21, 2019
Author Correction: A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutationS J Tavernier, V Athanasopoulos, P Verloo, et al.
Pageof 8